Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pemphigus Disease”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Testing effectiveness (Phase 2)Looking for participantsNCT04422912
What this trial is testing

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

Who this might be right for
Pemphigus Vulgaris
Cabaletta Bio 40
Not applicableUnknownNCT06285435
What this trial is testing

Coagulation Activation in Patients With Pemphigus

Who this might be right for
Pemphigus
Assiut University 54
Testing effectiveness (Phase 2)Ended earlyNCT03075904
What this trial is testing

A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)

Who this might be right for
PemphigusPemphigus VulgarisPemphigus Foliaceus
Alexion Pharmaceuticals, Inc. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04400994
What this trial is testing

IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus

Who this might be right for
Pemphigus
The University of Hong Kong 20
Not applicableLooking for participantsNCT07384221
What this trial is testing

Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients

Who this might be right for
Pemphigus Vulgaris (PV)Periodontal Diseases
Saglik Bilimleri Universitesi 20
Not applicableNot Yet RecruitingNCT06904040
What this trial is testing

A Single-center Study of CM313 in Patients With Pemphigus

Who this might be right for
Pemphigus
Sichuan Provincial People's Hospital 20
Not applicableStudy completedNCT06167408
What this trial is testing

Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients

Who this might be right for
Pemphigus Vulgaris
First Affiliated Hospital of Chongqing Medical University 96
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15
Large-scale testing (Phase 3)Study completedNCT00784589
What this trial is testing

Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus

Who this might be right for
Pemphigus Disease
University Hospital, Rouen 90
Not applicableUnknownNCT04117529
What this trial is testing

Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
Assistance Publique - Hôpitaux de Paris 40
Not applicableStudy completedNCT00213421
What this trial is testing

Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus

Who this might be right for
Bullous Pemphigoid
University Hospital, Rouen 330
Not applicableStudy completedNCT00960713
What this trial is testing

The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

Who this might be right for
PemphigusAuto-immune Thrombocytopenic PurpuraHemolytic Auto-immune Anaemia+2 more
University Hospital, Toulouse 35
Large-scale testing (Phase 3)Ended earlyNCT01920477
What this trial is testing

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Novartis Pharmaceuticals 35
Not applicableUnknownNCT04096222
What this trial is testing

Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients

Who this might be right for
Pemphigus VulgarisBullous DermatosesAutoimmune Diseases
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 42
Large-scale testing (Phase 3)Study completedNCT04598451
What this trial is testing

Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 222
Post-approval studies (Phase 4)UnknownNCT05303272
What this trial is testing

Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)

Who this might be right for
Pemphigus Vulgaris
Tongji Hospital 60
Large-scale testing (Phase 3)Study completedNCT00127764
What this trial is testing

European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus

Who this might be right for
Pemphigus
University Medical Center Groningen 60
Very early researchEnded earlyNCT01313923
What this trial is testing

Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus

Who this might be right for
Pemphigus
University of California, Irvine 3
Large-scale testing (Phase 3)Study completedNCT02383589
What this trial is testing

Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)

Who this might be right for
Pemphigus Vulgaris
Hoffmann-La Roche 135
Large-scale testing (Phase 3)Ended earlyNCT04598477
What this trial is testing

Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 183
Load More Results